Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gabapentin in 50 patients with epilepsy].

F Gracia-Fleta1, V Medrano-Martínez, M D Castaño-Pérez

  • 1Servicio de Neurología, Hospital General Universitario de Alicante, Alicante, España.

Revista De Neurologia
|April 11, 2001
PubMed
Summary

Gabapentin monotherapy effectively reduced partial and secondary generalized partial epileptic seizures by over 50% in 78% of patients. This anticonvulsant drug demonstrated good tolerability and safety in epilepsy treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reversible Homonymous Inferior Quadrantanopia in a Nonketotic Hyperglycemic Patient.

Neuro-ophthalmology (Aeolus Press)·2020
Same author

Alcock canal syndrome secondary to endometrial infiltration.

Neurologia (Barcelona, Spain)·2015
Same author

Eyelid myokymia in patients with migraine taking topiramate.

Acta neurologica Scandinavica·2015
Same author

Characteristics of informal caregivers of patients with dementia in Alicante province.

Neurologia (Barcelona, Spain)·2012
Same author

NARP syndrome in a patient harbouring an insertion in the MT-ATP6 gene that results in a truncated protein.

Journal of medical genetics·2009
Same author

[Preadmission statins treatment in stroke patients: opportunity to treat high vascular risk patients].

Revista de neurologia·2007

Area of Science:

  • Neurology
  • Clinical Pharmacology

Background:

  • Epilepsy management often requires effective monotherapy for partial and secondary generalized partial seizures.
  • Gabapentin is an anticonvulsant with potential for monotherapy in epilepsy.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of gabapentin as a monotherapy for recent-onset partial and secondary generalized partial epileptic seizures.
  • To assess gabapentin's effectiveness in treatment-naive patients and those refractory to other antiepileptic drugs.

Main Methods:

  • An open, prospective study involving 50 patients with partial and secondarily generalized partial epileptic seizures.
  • Patients received gabapentin, with treatment initiated at the first visit and followed for two years.
  • Dosing involved a progressive increase to a maintenance dose of 1,200 mg/day, with individual adjustments.

Related Experiment Videos

Main Results:

  • Gabapentin monotherapy was administered to 78% of the 50 study participants.
  • A 50% or greater reduction in seizure frequency was observed in all patients continuing gabapentin treatment, a statistically significant finding (p < 0.05).
  • Treatment was discontinued due to ineffectiveness in 10% of patients and due to side-effects in 12%.

Conclusions:

  • Gabapentin is a safe and effective anticonvulsant for monotherapy in patients with partial seizures.
  • The drug is well-tolerated, supporting its use in managing partial and secondary generalized partial epileptic seizures.